Immediate Impact
10 standout
Citing Papers
The role of BCL-2 family proteins in regulating apoptosis and cancer therapy
2022 Standout
Protein tyrosine kinase inhibitor resistance in malignant tumors: molecular mechanisms and future perspective
2022 Standout
Works of Sam Yuen being referenced
Phase 2 Study of Venetoclax Plus Rituximab or Randomized Ven Plus Bendamustine+Rituximab (BR) Versus BR in Patients with Relapsed/Refractory Follicular Lymphoma: Interim Data
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sam Yuen | 33 | 35 | 26 | 8 | 50 | |
| Simon Rule | 32 | 26 | 18 | 7 | 51 | |
| Amanda Gillespie-Twardy | 23 | 22 | 17 | 6 | 42 | |
| Josh Caddy | 29 | 20 | 13 | 7 | 42 | |
| Anna Alperovich | 26 | 18 | 16 | 9 | 41 | |
| Magda Alexis | 32 | 34 | 14 | 9 | 53 | |
| Sara Pezzatti | 27 | 40 | 6 | 10 | 62 | |
| Lanie E. Happ | 17 | 18 | 9 | 9 | 40 | |
| Nurgul Kilavuz | 27 | 47 | 7 | 6 | 55 | |
| Johanna Rimpiläinen | 20 | 21 | 6 | 7 | 43 | |
| Edoardo Simonetti | 37 | 23 | 42 | 9 | 64 |
All Works
Loading papers...